Bio-Techne (TECH) Exchange Rate Effect (2009 - 2026)
Bio-Techne's (TECH) quarterly Exchange Rate Effect came in at -$1.2 million in Q1 2026, down 9.9% year-on-year from -$1.3 million in Q1 2025, and down 387.65% quarter-over-quarter from $413000.0 in Q4 2025.
Bio-Techne (TECH) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Bio-Techne's Exchange Rate Effect history runs 18 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 9.9% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was $11.4 million, a 195.56% increase from a year earlier, with the FY2025 full-year figure at $11.9 million, up 611.23% from the prior year.
- Exchange Rate Effect fell to -$1.2 million in Q1 2026 per TECH's latest filing, from $413000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $13.4 million in Q2 2025 and bottomed at -$11.9 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$1.1 million (2023), against an average of -$383176.5.
- Across the five-year window, Exchange Rate Effect tumbled 4548.67% in 2022 and soared 569.18% in 2024, its largest moves.
- Year by year, Exchange Rate Effect stood at $7.3 million in 2022, then slumped by 53.4% to $3.4 million in 2023, then plunged by 259.74% to -$5.5 million in 2024, then soared by 107.55% to $413000.0 in 2025, then plunged by 387.65% to -$1.2 million in 2026.
- Per Business Quant, the three latest TECH Exchange Rate Effect figures stand at -$1.2 million (Q1 2026), $413000.0 (Q4 2025), and -$1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | -1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.19 Mn |
| Mar 31, 2026 | -1.19 Mn |
| Dec 31, 2025 | 413,000.00 |
| Dec 31, 2025 | 413,000.00 |
| Sep 30, 2025 | -1.21 Mn |
| Sep 30, 2025 | -1.21 Mn |
| Jun 30, 2025 | 13.36 Mn |
| Jun 30, 2025 | 13.36 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Dec 31, 2024 | -5.47 Mn |
| Dec 31, 2024 | -5.47 Mn |
| Sep 30, 2024 | 5.12 Mn |
| Sep 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Dec 31, 2023 | 3.42 Mn |